Location History:
- Stony Brook, NY (US) (2016 - 2021)
- Setauket, NY (US) (2023)
Company Filing History:
Years Active: 2016-2023
Title: Bruce Futcher: Innovator in Influenza Virus Research
Introduction
Bruce Futcher is a prominent inventor based in Stony Brook, NY (US). He has made significant contributions to the field of virology, particularly in the development of attenuated influenza viruses and vaccines. With a total of 6 patents, his work has the potential to enhance public health through innovative vaccine solutions.
Latest Patents
Futcher's latest patents focus on highly attenuated influenza viruses and vaccines. One of his notable inventions provides highly attenuated influenza viruses that proliferate well and possess high safety factors. These attenuated viruses offer protective immunity against challenges from viruses of the same subtype, as well as cross-protection against heterologous viruses. Another significant patent involves an attenuated virus with a modified viral genome containing nucleotide substitutions engineered in multiple locations. This invention introduces synonymous deoptimized codons into the genome, allowing the attenuated virus to be used in vaccine compositions that induce protective immune responses in subjects. Additionally, he has developed methods for synthesizing these attenuated viruses and for preventing virus-associated diseases through effective vaccine administration.
Career Highlights
Bruce Futcher is affiliated with the State University of New York, where he continues to advance his research in virology. His work has garnered attention for its innovative approach to vaccine development, particularly in the context of influenza viruses.
Collaborations
Futcher has collaborated with notable researchers in his field, including Eckard Wimmer and Steffen Mueller. These collaborations have contributed to the advancement of his research and the development of effective vaccine strategies.
Conclusion
Bruce Futcher's contributions to the field of influenza virus research are significant and impactful. His innovative patents and collaborations highlight his dedication to improving public health through advanced vaccine technologies.